Immix Biopharma Inc. (NASDAQ: IMMX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT IMMIX BIOPHARMA INC.

Immix Biopharma Inc. (NASDAQ: IMMX)
Listen to this Section


$2.00
+0.0300 ( +1.52% ) 49.8K

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Market Data


Open $2.00
Previous Close $1.97
Volume 49.8K
Market Cap $54.19M
Day Range $1.88 - $2.01
52 Week Range $1.26 - $3.80
Shares Outstanding 27.51M
Change % +1.52%
Net Change ▲ 0.0300
Insider Ownership 0.00%
Exchange NASDAQ
Sector Healthcare
Industry Medicinal Chemicals and Botanical Products
IPO Year 2021
Country United States
Under Writer ThinkEquity, more

Insider Ownership Transactions

Total Amount Purchased: -1,774,425.00

Date Type Amount Purchased Purchaser
2024-12-26 Buy 7700.00 Hsu Jason
2024-08-26 Buy 15000.00 Hsu Jason
2024-08-19 Buy 10000.00 Ng Carey
2024-07-31 Buy 3200.00 Hsu Jason
2024-06-21 Sale -33000.00 Chudnovsky Yekaterina
2024-06-21 Sale -33000.00 Hsu Jason
2024-06-21 Sale -33000.00 Ng Carey
2024-06-21 Sale -340000.00 Rachman Ilya M
2024-06-21 Sale -340000.00 Morris Gabriel S
2024-06-21 Sale -33000.00 BUCHAN JANE

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 14, 2024
4 Insider transactions 1 May 14, 2024
10-q Quarterly Reports 63 May 09, 2024
ars Annual reports 1 Apr 30, 2024
def Proxies and info statements 1 Apr 29, 2024
10-k Annual reports 78 Mar 29, 2024
s-8 Registration statements 4 Feb 20, 2024
424b5 Other 2 Feb 07, 2024

Latest News


× Before browsing our site, please accept our cookies policy